Sanofi-aventis; Bristol-Myers Squibb
Paris (ots/PRNewswire) - - PLAVIX indication expanded to include patients with any acute coronary syndromes (ACS) - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the European Commission has granted a new indication for the antiplatelet ...
New York (ots/PRNewswire) - - Heart Disease Patients who Were at a Very High Risk for Having a Second Heart Attack and Took Lipitor 80mg Had a 46 Percent Reduction in the Risk of Experiencing Additional Heart Attacks Compared With Patients Taking Simvastatin - Investigator: 'These data suggest the benefit ...
Basel, Switzerland (ots/PRNewswire) - - First Treatment for Years to Have Shown a Significant Survival Benefit for Patients Roche announced today that it has requested a re-examination of the data supporting the filing of their breakthrough cancer medicine, Tarceva, for the treatment of pancreatic cancer ...
Hospital Pitie Salpetriere-Institut du coeur
Barcelona, Spain (ots/PRNewswire) - Results of the multinational, prospective, observational RIVIERA registry (Registry on IntraVenous anticoagulation In the Elective and primary Real world of Angioplasty) announced today at the World Congress of Cardiology 2006- joint meeting of the European Society of ...
New York (ots/PRNewswire) - - Lipitor Reduces Risk of Major Cardiovascular Events Such as Heart Attacks in People With Heart Disease and With a Cluster of Other Major Cardiovascular Risk Factors, Often Referred to as Metabolic Syndrome, New Analysis Shows - Heart Disease Patients With Metabolic Syndrome who Took Lipitor 80mg Dose Reduced Their Risk of Major Cardiovascular Events by Nearly 30 ...
Barcelona (ots/PRNewswire) - - Results of the PCI-ExTRACT Sub-Study Results of the PCI-ExTRACT-TIMI 25 study announced today at the World Congress of Cardiology-European Society of Cardiology 2006 in Barcelona, showed that among patients with ST-segment elevation myocardial infarction (STEMI) who ...
Barcelona, Spain (ots/PRNewswire) - - Coversyl(R) in PEP-CHF Trial, is the First Agent to Demonstrate Clinical Benefits in Elderly Heart Failure Patients With Diastolic Dysfunction The ACE inhibitor Coversyl(R) (perindopril) provides a number of clinical benefits to elderly people with chronic heart failure according to the results of a study presented at ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 31.08.2006 Pfaeffikon SZ, 31 August 2006 --- For the first six months ending 30 June 2006 shaPEs share price gained 3.2% to CHF 224.00 while the Net Asset Value (NAV) per share decreased by 2.7% to CHF 228.21. The reduced NAV per share relates to ...
Edmonton, Alberta (ots/PRNewswire) - - Isotechnika Inc. announced today promising results from its Phase I TAFA93 trials. TAFA93, a pro-drug of rapamycin, is a novel small molecule mTOR inhibitor, which is a class of drugs currently used in the prevention of organ rejection in transplantation. mTOR inhibitors are typically used in combination with ...
The Alliance for Better Bone Health
Paris, France (ots/PRNewswire) - - Male Osteoporosis: Neglected and Under Treated PARIS, France, August 17 /PRNewswire/ -- The US Food and Drug Administration (FDA) this week approved Actonel(R) 35mg (risedronate sodium tablets) for 'treatment to increase bone mass in men with osteoporosis'. This follows the positive outcome in July 2006 of the European application for the additional indication of ...
Toronto (ots/PRNewswire) - - TMC125 a Next-Generation NNRTI Tibotec Pharmaceuticals Ltd. presented 48 week efficacy and safety data on TMC125, a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), at the 16th International AIDS conference (IAC), AIDS 2006, in Toronto, Canada this week. TMC125 is currently being investigated in phase 3 trials (DUET 1 and 2) in treatment-experienced adult ...
Toronto (ots/PRNewswire) - New data on tipranavir oral solution from a Phase II dose finding study in 115 HIV-1 infected children aged 2 to 18 years were announced today at the 16th International AIDS Conference (IAC) in Toronto, Canada. Results from this 48-week analysis show that patients achieved virologic ...
Basel, Switzerland (ots/PRNewswire) - - FUZEON Combined With New Protease Inhibitors Provides Best Hope for Patients who Have Been Battling Resistant Virus During the world's largest HIV/AIDS congress in Toronto (XVI International AIDS Conference) new guidelines from the influential International AIDS ...
Bill & Melinda Gates Foundation
Toronto (ots/PRNewswire) - - Joint Keynote at AIDS Conference Highlights Need to Accelerate Research on New HIV Prevention Tools - Especially Microbicides - to Empower Women Bill and Melinda Gates today called upon world leaders to "put the power to prevent HIV in the hands of women" by accelerating the search for microbicides and other new HIV prevention ...
Bunnik, The Netherlands (ots/PRNewswire) - AM-Pharma B.V., a biopharmaceutical company engaged in the pre-clinical and early clinical development of novel compounds to treat infectious and inflammatory diseases, announces the issuance of the patent for one of its lead products, the antimicrobial peptide hLF1-11, ...
Cape Town, South Africa (ots/PRNewswire) - "We can really do something to change the world," says Archbishop Desmond Tutu. "I think not being able to see is one of the most debilitating disabilities in our world today," Archbishop Tutu said at the launching of Christian Blind Mission's worldwide "100,000 Miracles" campaign at an International Press Conference held ...
Toronto, Canada (ots/PRNewswire) - Medify Solutions Limited Today Announced the Appointment of Gayle E. Hanlon, as its Group Company Secretary Effective 1 August 2006. Ms. Hanlon, a US business lawyer representing several German and Swiss corporations in their respective international corporate, commercial ...
Gateshead, England (ots/PRNewswire) - From the 1st July 2006 Ian O'Reilly was appointed the Group CEO of the Medify Solutions (OTC: MFYS) group of companies. One month into the role, O'Reilly provides the following assessment as to the state of the business. "It has been obvious from the outset of my involvement with Medify that massive potential exists for the Company, the products and this emerging market. Having ...
Toronto (ots/PRNewswire) - Over the past month, Medify Solutions Limited (OTC: MFYS) has conducted a full and extensive review of its commercial model being operated and going forward in the UK, European and global markets. This exercise has examined the various options that exist in the market, with the prime focus of adopting the one which shows the greatest ...
Gateshead, England (ots/PRNewswire) - On the 1st September 2006, Medify Solutions Limited will roll out its 'remote access to patient notes' product, MedifyRemote, to its National Health Service (NHS) customers. The first NHS site, as published previously , will be in Doncaster in the north of England. This ...
Gateshead, England (ots/PRNewswire) - Due to the number of product sales enquiries from UK based NHS GP practices, Medify Solutions Limited would like to clarify the product availability situation. The first production release of Medify Remote is scheduled to be utilised at Doncaster Central PCT from 1st September 2006. No live GP practice, PCT sales or installations will occur until this date. Confirming the ...
Macclesfield, England (ots/PRNewswire) - - International Panel of Breast Cancer Specialists Agree: 'With Successful Adjuvant Therapy, Early Breast Cancer is Potentially a Curable Condition.' - ATTN: Health Professional Press - For International Journalists - Not for US Media Today, leading breast cancer experts advised unequivocally that 5 years' ...
New York (ots/PRNewswire) - - More Than 1.2 Million Europeans Die of Smoking-Related Diseases Each Year; An Estimated US$500 Billion in Global Health-Related Costs by 2010 - Medical Expert: 'Helping smokers quit is one of the most important things a physician can do to improve their patients' overall health and reduce the risk of developing serious ...
Basel, Switzerland (ots/PRNewswire) - Roche announced today that its cancer medicine Tarceva (erlotinib) has received a negative opinion from the European Committee for Medicinal Products for Human Use (CHMP) for use in combination with gemcitabine chemotherapy for the first line treatment of advanced pancreatic ...
Madrid (ots/PRNewswire) - PharmaMar today announces the submission of a Marketing Authorization Application to the European Medicines Agency (EMEA) for Yondelis(R) (trabectedin) as a treatment for soft tissue sarcomas (STS). The application is based on the results of a randomised, Phase II pivotal study of ...
Madrid, Spain (ots/PRNewswire) - Corporate: - Zeltia performs 1-for-50 bonus issue - Group revenues amounted to 42.5 million euro. - Investment in R&D amounted to 24.4 million euro in the first half of 2006. - The net cash position (cash + cash equivalents + current financial assets - short-term borrowings) amounted to 55.3 million euro. PharmaMar: - Excellent results of Yondelis in myxoid ...
Gateshead, England (ots/PRNewswire) - Remote Technology Company Medify Solutions (Pink Sheets: MFYS) is delighted to announce its expansion into the European market with Oracle as business partner, the world's largest enterprise software company. Following the positive collaborative achievements of Medify with ...
Global Lung Cancer Coalition (GLCC)
London (ots/PRNewswire) - The Tempus Journalism Awards, launched earlier this year by the Global Lung Cancer Coalition (GLCC), is the first global initiative to recognise excellence in lung cancer reporting. There are still two months remaining before judging begins - so please continue to send in your submissions. Remember, entries are invited from journalists whose features, commentaries or programmes on lung ...
Toronto (ots/PRNewswire) - Remote technology company Medify International announced today that it is building on its UK collaboration with Oracle, the world's largest enterprise software company, and expanding across Europe. Following the success of its collaborative approach with Oracle in delivering a tried and tested system for remote access to ...
Gateshead, England (ots/PRNewswire) - Medify Solutions Limited (Pink Sheets: MFYS) confirms the scheduled go-live date for MedifyRemote to its NHS customers is 1st September 2006. Executive Chairman Jonathan Bryant said, "The confirmation of the go live date for MedifyRemote is an announcement we have all been waiting for - significant projected revenue, seats and profit realised. With the new product, in-house managed service and the share dividend qualification date ...